By Joyce Frieden, News Editor, MedPage Today WASHINGTON — The FDA has approved the first meningococcal vaccine for use in toddlers and infants as young as nine months of age. The vaccine, called Menactra, is already approved for use in people ages 2 through 55 for prevention of invasive meningococcal disease caused by Neisseria meningitidis […]
The Norwegian Institute of Public Health’s annual report for the HPV vaccine in the childhood vaccination programme indicates that vaccination coverage in the first two cohorts of girls is over 65%. The highest percentage among girls born in 1997 was in Sogn og Fjordane, where 77% received at least one dose. The lowest was in […]
Tuesday, February 22, 2011 by: Alan Phillips, J.D.
Health authorities around the country are set on further restricting vaccine exemption rights, probably due to the growing awareness of vaccine problems and increase in exemptions around the country. Currently, proposed laws in Washington State and New Jersey would limit the ability of residents in those states to refuse vaccines. If not stopped, those new restrictions will soon become law and pave the way for further restrictions across the country. Predictably, anti-vaccine activists are opposing these bills, but with state health departments and well-financed pharmaceutical lobbyists on the other side, is a grass roots effort likely to succeed? Hopefully so, but if the proposed laws are shown to raise significant Constitutional issues, anti-vaccine activists may find that they have a “David” advantage against the “Goliath” opposition.
Saturday, February 19, 2011 by: Ethan A. Huff, staff writer
Two British doctors recently wrote a piece in the BBC urging the U.K. National Health Service (NHS) to switch from Merck’s Cervarix human papillomavirus (HPV) vaccine to GlaxoSmithKline’s (GSK) Gardasil HPV vaccine, in its mass vaccination program for young girls. And the two “experts” admit that they only say publicly what helps the vaccine to be well received by the public.
“We, as consultants in sexual health, have been told to say nothing publicly that would damage the current (HPV) vaccine campaign,” they state in their piece.
MedScape News Author: Laurie Barclay, MD CME Author: Charles P. Vega, MD Authors and Disclosures Posted: 01/31/2011 CME/CE Released: 02/03/2011; Valid for credit through 02/03/2012 February 3, 2011 — In October 2010, the Advisory Committee on Immunization Practices (ACIP) approved the Adult Immunization Schedule for 2011, which includes several changes. The 2011 schedule, which reflects current recommendations […]